TRPV1 and epidermolysis bullosa: When TG2 activity was inhibited by CTM treatment, the cough frequency in EB model mice was alleviated (Fig. 6g), and consistently the induction levels of IL-4, IL-13, IL-6, Mcpt7, TRPA1 and TRPV1 in EB were reduced.